NCT04879329 2026-01-07A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2Seagen Inc.Phase 2 Recruiting372 enrolled
NCT05912205 2023-06-22Disitamab Vedotin Combined With Radiotherapy for Bladder PreservationUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 2 Not yet recruiting30 enrolled